pmid,title,journal,year,drug,disease
40934429,Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2.,The Journal of clinical investigation,2025,Molnupiravir,COVID-19
40933128,Isolation of a SARS-CoV-2 strain from pediatric patients in South Korea: biologic and genetic characterization.,Frontiers in microbiology,2025,Molnupiravir,COVID-19
40931314,Cardiovascular Safety of COVID-19 Treatments: A Disproportionality Analysis of Adverse Event Reports from the WHO VigiBase.,Infectious diseases and therapy,2025,Molnupiravir,COVID-19
40929093,Structure Elucidation and In-Silico Safety Assessment of a Degradation Impurity in Molnupiravir Capsule Formulation: Development of a Stability-Indicating Method for Related Substances.,Journal of AOAC International,2025,Molnupiravir,COVID-19
40913022,Development of GFP-expressing infectious clones for PRRSV using TAR cloning for antiviral drug screening.,Npj viruses,2025,Molnupiravir,COVID-19
40908598,"Inequities in COVID-19 antiviral dispensation in Victoria, Australia: A retrospective cohort study using linked data.",Australian journal of general practice,2025,Molnupiravir,COVID-19
40905188,Effectiveness of molnupiravir for the treatment of COVID-19: a systematic literature review of real-world observational studies.,Current medical research and opinion,2025,Molnupiravir,COVID-19
40904363,Good syndrome presenting with multiple pulmonary infections: a case report involving metagenomic sequencing diagnosis.,Frontiers in medicine,2025,Molnupiravir,COVID-19
40900943,Mechanism and spectrum of inhibition of viral polymerases by 2'-deoxy-2'-beta-fluoro-4'-azidocytidine or azvudine.,NAR molecular medicine,2025,Molnupiravir,COVID-19
40896198,"Population Pharmacokinetic Modeling Analysis of ASC10, a Novel Antiviral Agent Targeted COVID-19, in Chinese Healthy Subjects.","Drug design, development and therapy",2025,Molnupiravir,COVID-19
40888812,"Placental transfer of medications to treat COVID-19, molnupiravir, favipiravir and nirmatrelvir/ritonavir, in the ex vivo human cotyledon model.",The Journal of antimicrobial chemotherapy,2025,Molnupiravir,COVID-19
40867841,Selective Inhibition of Vascular Smooth Muscle Cell Function by COVID-19 Antiviral Drugs: Impact of Heme Oxygenase-1.,"Antioxidants (Basel, Switzerland)",2025,Molnupiravir,COVID-19
40872842,Pharmacological and Adjunctive Management of Non-Hospitalized COVID-19 Patients During the Omicron Era: A Systematic Review and Meta-Analysis.,Viruses,2025,Molnupiravir,COVID-19
40872778,SARS-CoV-2 Infection and Antiviral Strategies: Advances and Limitations.,Viruses,2025,Molnupiravir,COVID-19
40872297,Molnupiravir Inhibits Replication of Multiple Alphacoronavirus suis Strains in Feline Cells.,"Pathogens (Basel, Switzerland)",2025,Molnupiravir,COVID-19
40787985,SARS-CoV-2 causes chronic lung inflammation and impaired respiratory capacity in aged Roborovski dwarf hamsters.,Journal of virology,2025,Molnupiravir,COVID-19
40741617,Multitarget-based in silico screening from phytoactive compounds of Garcinia linii fighting toward severe acute respiratory syndrome coronavirus-2.,Tzu chi medical journal,2025,Molnupiravir,COVID-19
40736492,Top 20 Research Studies of 2024 for Primary Care Physicians.,American family physician,2025,Molnupiravir,COVID-19
40733581,"3,3'-Diindolylmethane Improves the Viral Pneumonia Outcomes After Influenza and SARS-CoV-2 Infection in Animal Models.",Viruses,2025,Molnupiravir,COVID-19
40733041,Carboxylesterase Factors Influencing the Therapeutic Activity of Common Antiviral Medications Used for SARS-CoV-2 Infection.,Pharmaceutics,2025,Molnupiravir,COVID-19
40732763,Efficacy of GS-441524 for Feline Infectious Peritonitis: A Systematic Review (2018-2024).,"Pathogens (Basel, Switzerland)",2025,Molnupiravir,COVID-19
40732713,Pharmacokinetics of Molnupiravir in Cats with Naturally Occurring Feline Infectious Peritonitis.,"Pathogens (Basel, Switzerland)",2025,Molnupiravir,COVID-19
40730007,The combinatorial activities of oseltamivir and molnupiravir against influenza virus infections in vitro and in vivo.,Virology,2025,Molnupiravir,COVID-19
40721474,SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVID-19: cohort study.,Nature communications,2025,Molnupiravir,COVID-19
40692086,Detection of developmental toxicity of the anti-COVID-19 drug molnupiravir using gastruloid-based in vitro assays.,Toxicological sciences : an official journal of the Society of Toxicology,2025,Molnupiravir,COVID-19
40664729,Development and validation of a RP-HPLC method for simultaneous determination of five COVID-19 antiviral drugs in pharmaceutical formulations.,Scientific reports,2025,Molnupiravir,COVID-19
40659960,On degree-dependent topological study of line graph of some antiviral COVID-19 drugs.,"The European physical journal. E, Soft matter",2025,Molnupiravir,COVID-19
40613103,A cost-effectiveness analysis of Molnupiravir and Paxlovid for outpatient treatment of COVID-19 in three African countries.,Journal of public health in Africa,2025,Molnupiravir,COVID-19
40605295,[Recurrent COVID-19 in a patient with Good's syndrome: a case report and literature review].,Zhonghua nei ke za zhi,2025,Molnupiravir,COVID-19
40600448,In Vitro Synergistic Antiviral Effects of beta-D-N4-hydroxycytidine and Teriflunomide in Combination against a Broad Range of RNA Viruses.,Journal of medical virology,2025,Molnupiravir,COVID-19
40591358,Racial Inequities and Access to COVID-19 Treatment.,JAMA network open,2025,Molnupiravir,COVID-19
40575972,Successful salvage therapy of ruxolitinib on interstitial pneumonia after long COVID or post-COVID-19 syndrome with follicular lymphoma: two case reports and literature review.,Chinese clinical oncology,2025,Molnupiravir,COVID-19
40561865,Synergistic interference with SARS-CoV-2 replication by molnupiravir-derived N(4)-hydroxycytidine and inhibitors of CTP synthetase in cell culture.,Virology,2025,Molnupiravir,COVID-19
40549074,An in-vitro and in-silico approaches in exploring the molecular contact of COVID-19 antiviral drug molnupiravir with human serum albumin: effect of binding on protein structure.,Journal of computer-aided molecular design,2025,Molnupiravir,COVID-19
40543494,"Characterization of the tautomeric equilibrium of molnupiravir, an antiviral for the treatment of COVID-19.",Journal of pharmaceutical and biomedical analysis,2025,Molnupiravir,COVID-19
40509573,Structural Basis and Rational Design of Nucleotide Analogue Inhibitor Evading the SARS-CoV-2 Proofreading Enzyme.,Journal of the American Chemical Society,2025,Molnupiravir,COVID-19
40503169,Autophagy-enhancing strategies to promote intestinal viral resistance and mucosal barrier function in SARS-CoV-2 infection.,Autophagy reports,2025,Molnupiravir,COVID-19
40492088,Factors Associated with Seeking and Receiving Home Antiviral Therapy During the COVID-19 Pandemic.,medRxiv : the preprint server for health sciences,2025,Molnupiravir,COVID-19
40485270,Pandemic Preparation and Response in Long-Term Care Hospitals: Lessons from COVID-19 Outbreaks and Preparedness for Future Infectious Diseases.,Annals of geriatric medicine and research,2025,Molnupiravir,COVID-19
40470763,Development of molnupiravir and peramivir loaded liposome formulations for combined antiviral therapy.,Pharmaceutical development and technology,2025,Molnupiravir,COVID-19
40449990,Reevaluating the role of molnupiravir in COVID-19 treatment.,Expert review of anti-infective therapy,2025,Molnupiravir,COVID-19
40441732,Drug treatments for mild or moderate covid-19: systematic review and network meta-analysis.,BMJ (Clinical research ed.),2025,Molnupiravir,COVID-19
40424099,Efficacy of oral remdesivir in treating feline infectious peritonitis: a prospective observational study of 29 cats.,Journal of feline medicine and surgery,2025,Molnupiravir,COVID-19
40419748,Construction and validation of a cell based reporter assay for identifying inhibitors of SARS coronavirus 2 RNA dependent RNA polymerase activity.,Scientific reports,2025,Molnupiravir,COVID-19
40409569,"Germline mutagenicity of molnupiravir and its active form, beta-d-N4-hydroxycytidine, in Caenorhabditis elegans evaluated using whole-genome sequencing.",Toxicology letters,2025,Molnupiravir,COVID-19
40409224,"Real-world effectiveness and economic analysis of nirmatrelvir/ritonavir, remdesivir, and molnupiravir for treatment of COVID-19 among ambulatory patients in Thailand.",Journal of infection and public health,2025,Molnupiravir,COVID-19
40385477,Honeysuckle extracts as a potential inhibitor of SARS-CoV-2 infection.,Frontiers in pharmacology,2025,Molnupiravir,COVID-19
40383127,"Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.",The Lancet. Infectious diseases,2025,Molnupiravir,COVID-19
40359762,Electrochemical interpretations for the study of molnupiravir binding interactions with bovine serum albumin and DNA and molecular dynamics studies.,Biochemical and biophysical research communications,2025,Molnupiravir,COVID-19
40349125,Benzoyl Chloride Derivatization Coupled With Liquid Chromatography-Mass Spectrometry for the Simultaneous Quantification of Molnupiravir and Its Metabolite beta-d-N(4)-hydroxycytidine in Human Plasma.,Journal of separation science,2025,Molnupiravir,COVID-19
